Wed, Oct 1, 2014, 12:03 PM EDT - U.S. Markets close in 3 hrs 57 mins

Recent

% | $
Quotes you view appear here for quick access.

GlaxoSmithKline plc Message Board

  • usagary1 usagary1 Nov 19, 2012 11:54 AM Flag

    Things to watch for

    Revolade/Promacta(eltrombopag)† thrombopoietin receptor agonist hepatitis C induced thrombocytopaenia Phase III
    Tyverb/Tykerb (lapatinib) Her2 and EGFR dual kinase inhibitor head & neck squamous cell carcinoma (resectable disease) Phase III
    Tyverb/Tykerb (lapatinib) Her2 and EGFR dual kinase inhibitor gastric cancer Phase III
    Tyverb/Tykerb (lapatinib) human epidermal growth factor receptor-2 (Her2) and epidermal growth factor receptor (EGFR) dual kinase inhibitor breast cancer, adjuvant therapy Phase III
    Votrient (pazopanib) multi-kinase angiogenesis inhibitor ovarian cancer, maintenance therapy Phase III
    Votrient (pazopanib) multi-kinase angiogenesis inhibitor renal cell cancer, adjuvant therapy Phase III
    dabrafenib (2118436) BRaf protein kinase inhibitor metastatic melanoma Phase III
    trametinib (1120212)† MEK1/2 inhibitor metastatic melanoma Phase III
    Tyverb/Tykerb (lapatinib) Her2 and EGFR dual kinase inhibitor metastatic breast cancer, in combination with trastuzumab Submitted S: Feb12 S: Feb12
    Votrient (pazopanib) multi-kinase angiogenesis inhibitor sarcoma Submitted S: Jul11 S: Jun11

 
GSK
45.98+0.0100(+0.02%)12:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.